Leaderboards/Cholangiocarcinoma and Gallbladder Cancer Studies

Cholangiocarcinoma and Gallbladder Cancer Studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Harriet Rumgay
Centre international de recherche sur le cancer
2
Gajanan Kendre
National Institute of Technology Rourkela
3
A. Vogel
Princess Margaret Cancer Centre
4
Xiaoqiang Chai
Buchang Pharma (China)
5
Miguel A. Martín-Serrano
Icahn School of Medicine at Mount Sinai
6
Chu‐Bin Luo
Sun Yat-sen University
7
Mao Yang
Shanghai Jiao Tong University
8
Leilani Lakemeyer
University Hospital Ulm
9
Stijn Franssen
Erasmus MC Cancer Institute
10
Colm J. O’Rourke
University of Copenhagen

Papers

1
Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis
The Lancet Oncology|2024
97 cit.
2
Publication in ESMO Open (2024) [70 citations, W4405475772]
ESMO Open|2024
70 cit.
3
Publication in Cancer Cell (2025) [15 citations, W4408290484]
Cancer Cell|2025
15 cit.
4
Publication in Journal of Clinical Oncology (2024) [12 citations, W4391096766]
Journal of Clinical Oncology|2024
12 cit.
5
Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022
CA A Cancer Journal for Clinicians|2025
10 cit.
6
Publication in Journal of Clinical Oncology (2025) [6 citations, W4415192866]
Journal of Clinical Oncology|2025
6 cit.
7
Publication in JHEP Reports (2025) [5 citations, W4414121485]
JHEP Reports|2025
5 cit.
8
Publication in Annals of Oncology (2024) [3 citations, W4402561806]
Annals of Oncology|2024
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Fareeda Y. Coxon
Newcastle upon Tyne Hospitals NHS Foundation Trust
2
Mario Berríos
Hospital Universitario Central de Asturias
3
Lori Boice
Mayo Clinic
4
Tara Skelly
University of North Carolina at Chapel Hill
5
Vishal C. Chandan
University of California, Irvine
6
Tom Bodenheimer
University of North Carolina at Chapel Hill
7
Pei Lin
The University of Texas MD Anderson Cancer Center
8
Xingming Jiang
Harbin Medical University
9
Yeqiang Liu
Tongji University
10
Jean-Marc Phelip
Centre Hospitalier Universitaire de Saint-Étienne

Papers

1
Deep learning in multiple animal tracking: A survey
Computers and Electronics in Agriculture|2024
39 cit.
2
PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1
Aging|2022
29 cit.
3
Upregulation of circ_0059961 suppresses cholangiocarcinoma development by modulating miR-629-5p/SFRP2 axis
Pathology - Research and Practice|2022
13 cit.
4
LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling
Cancer Gene Therapy|2024
12 cit.
5
Deoxynivalenol exposure induces oxidative stress and apoptosis in human keratinocytes via PI3K/Akt and MAPK signaling pathway
Environmental Toxicology|2023
10 cit.
6
Circular <scp>RNA</scp> nuclear receptor interacting protein 1 promoted biliary tract cancer <scp>epithelial‐mesenchymal transition</scp> and stemness by regulating the <scp>miR</scp> ‐515‐5p/ <scp>AKT2</scp> axis and <scp>PI3K</scp> / <scp>AKT</scp> / <scp>mTOR</scp> signaling pathway
Environmental Toxicology|2023
7 cit.
7
Circ_0007534 promotes cholangiocarcinoma stemness and resistance to anoikis through DDX3X-mediated positive feedback regulation of parental gene DDX42
Cellular Signalling|2024
7 cit.
8
A mutation in CCDC91, Homo sapiens coiled-coil domain containing 91 protein, cause autosomal-dominant acrokeratoelastoidosis
European Journal of Human Genetics|2024
7 cit.
9
Role of mRNA-binding proteins in retinal neovascularization
Experimental Eye Research|2024
6 cit.
10
Eruptive Xanthomas
New England Journal of Medicine|2022
5 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
2
William R. Jarnagin
Memorial Sloan Kettering Cancer Center
3
John Bridgewater
University College London Hospitals NHS Foundation Trust
4
Timothy M. Pawlik
Northeastern University
5
Yuman Fong
City Of Hope National Medical Center
6
Andrew X. Zhu
Icahn School of Medicine at Mount Sinai
7
Timothy M. Pawlik
The Ohio State University
8
Charles J. Yeo
Thomas Jefferson University
9
Gregory J. Gores
Mayo Clinic in Arizona
10
Ronald P. DeMatteo
University of Pennsylvania

Papers

1
Comprehensive molecular characterization of gastric adenocarcinoma
Nature|2014
6.5k cit.
2
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
New England Journal of Medicine|2010
4.4k cit.
3
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
Annals of Surgery|1999
3.7k cit.
4
Two Hundred Gastrointestinal Stromal Tumors
Annals of Surgery|2000
2.5k cit.
5
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
The Lancet Oncology|2018
2.5k cit.
6
Hepatobiliary Cancers
Journal of the National Comprehensive Cancer Network|2009
2.3k cit.
7
Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990s
Annals of Surgery|1997
1.8k cit.
8
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology|2019
1.7k cit.
9
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Journal of Hepatology|2014
1.5k cit.
10
EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer
Unknown Journal|2012
1.5k cit.

Reagents for Cholangiocarcinoma and Gallbladder Cancer Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 64

LSD1 Antibody

Cited in 5 papers
#2139$317
View Evidence →
Cell Signaling TechnologyEvidence 65

PCNA (D3H8P) Rabbit Monoclonal Antibody

#13110$1,811,015
View Evidence →
Cell Signaling TechnologyEvidence 65

Puma Antibody

#4976$136,317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

Src Antibody Sampler Kit

Cited in 11 papers
#9935$509
View Evidence →
Agilent/Dako

Cytokeratin 7

Cited in 7 papers
#M7018
View Evidence →
RocheEvidence 75

VENTANA® anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody

Cited in 5 papers
#760-5095 (also 08033706001)
View Evidence →